The global catecholamine market is on a trajectory of remarkable expansion, with projections estimating its valuation to surge from USD 4.6 billion in 2024 to an impressive USD 9.3 billion by 2034. This growth, anticipated at a compound annual growth rate (CAGR) of 7.2%, reflects the increasing demand for catecholamine-based therapies and the advancements in …